Clinical Trials

In partnership with South Western Sydney Local Health District (SWSLHD), the Ingham Institute supports and facilitates over 200 active clinical trials across a broad range of therapeutic areas.

By conducting clinical trials in South Western Sydney, we ensure our local communities – one of the most culturally diverse populations in Australia – are represented in research that shapes the future of healthcare.

What are clinical trials?

Clinical trials are carefully designed research studies that test new ways to prevent, diagnose, treat, or manage health conditions. These trials are essential to developing better standards of care and improving health outcomes.

They may investigate:

  • New drugs or treatment
  • Diagnostic techniques
  • Quality of life improvements
  • Lifestyle interventions
  • Symptom management strategies
  • Long-term survivorship care

All clinical trials follow strict regulatory and ethical frameworks, and participant eligibility is determined by defined inclusion and exclusion criteria.

Phases of a clinical trial

Clinical trials are conducted in phases, each serving a different purpose in evaluating a treatment’s safety and effectiveness:

Phase I

First-in human trials involving a small group of participants to test safety, dosage and tolerability. These are typically short and highly supervised.

Phase II

Focuses on assessing the safety and effectiveness of an intervention in individuals with a specific condition. These trials involve a slightly larger group and are still closely monitored.

Phase III

Large-scale trials, often global, designed to compare the new treatment against the current standard of care. These assess clinical effectiveness and monitor side effects in diverse populations.

Phase IV

Post-marketing studies conducted after a treatment has been approved by the Therapeutic Goods Administration (TGA). These trials monitor long-term effects in real-world clinical practice.

Ms Nisha Berthon-Jones

Executive Director Clinical Trials
Ingham Institute and SWSLHD

Clinical trials are bridges to possibility—offering patients access to tomorrow’s treatments, today.

Though not every trial brings a cure, each one moves science forward and brings families the gift of hope and more moments that matter.

Ms Nisha Berthon-Jones